Mobile

International study evaluating safety of Obinutuzumab alone or in combination with chemotherapy in patients with Chronic Lymphocytic Leukemia

Update Il y a 4 ans
Reference: EUCTR2013-000087-29

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

• To evaluate the safety and tolerability of obinutuzumab alone or in combination with chemotherapy

Inclusion criteria

  • Chronic lymphocytic leukemia

Links